tirzepatide landmark trial for masld Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders Tirzepatide (Mounjaro) In Sherman Oaks

Weight changes in midlife aren't a mystery

By effectively decreasing HbA1c levels and supporting weight loss, tirzepatide aids in preventing cardiovascular complications, nephrotoxicity, and neurotoxicity, which are key contributors to recurrent hospitalization and escalating healthcare costs

Are you struggling with long-term weight management, tired of fad diets, you want the benefits of tirzepatide without the cost associated with brand names like Zepbound

Pancreatitis risk, though rare (0.1-0.5% in post-market data), requires vigilance throughout treatment

The FDA declared the tirzepatide shortage resolved in October 2024